{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:20:53Z","timestamp":1774988453249,"version":"3.50.1"},"reference-count":62,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007771","name":"\u015al\u0105ski Uniwersytet Medyczny","doi-asserted-by":"publisher","award":["KNW-2-O26\/N\/9\/K, KNW-1-037\/K\/9\/O"],"award-info":[{"award-number":["KNW-2-O26\/N\/9\/K, KNW-1-037\/K\/9\/O"]}],"id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Minocycline is a tetracycline compound with pleiotropic pharmacological properties. In addition to its antibacterial action, it shows many non-antimicrobial effects, including an anti-cancer activity. The anti-cancer action was confirmed in studies on ovarian carcinoma cells, hepatocellular carcinoma cells, glioma cells, or acute myeloid leukemia cells. Malignant melanoma remains a serious medical problem despite the extensive knowledge of the disease. The low effectiveness of the standard treatment, as well as the resistance to therapy, result in high mortality rates. This work aimed to investigate the potential and mechanisms of anti-melanoma action of minocycline. Human skin melanotic melanoma cell line COLO 829 was used in the study. The obtained results showed that minocycline decreased cell viability and inhibited the growth of melanoma cells, proportional to the drug concentration as well as to the time of incubation. The EC50 values were calculated to be 78.6 \u00b5M, 31.7 \u00b5M, and 13.9 \u00b5M for 24 h, 48 h, and 72 h, respectively. It was observed that treated cells had a disturbed cell cycle and significantly changed morphology. Moreover, minocycline caused a decrease in mitochondrial membrane potential and an increase in cells with a low level of reduced thiols. Finally, it was found that the anti-melanoma effect of minocycline was related to the induction of apoptosis. The drug activated caspases 8, 9, and 3\/7 as well as increased the number of annexin V-positive cells. The presented results show that minocycline possesses anti-melanoma potential.<\/jats:p>","DOI":"10.3390\/ijms21186917","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T08:18:01Z","timestamp":1600676281000},"page":"6917","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cellular and Molecular Aspects of Anti-Melanoma Effect of Minocycline\u2014A Study of Cytotoxicity and Apoptosis on Human Melanotic Melanoma Cells"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8260-4339","authenticated-orcid":false,"given":"Jakub","family":"Rok","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, Jagiello\u0144ska 4, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzanna","family":"Rzepka","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, Jagiello\u0144ska 4, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2247-3004","authenticated-orcid":false,"given":"Artur","family":"Beberok","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, Jagiello\u0144ska 4, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Pawlik","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, Jagiello\u0144ska 4, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6918-3330","authenticated-orcid":false,"given":"Dorota","family":"Wrze\u015bniok","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, Jagiello\u0144ska 4, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/CMR.0b013e328351fa4d","article-title":"A brief history of melanoma: From mummies to mutations","volume":"22","author":"Rebecca","year":"2012","journal-title":"Melanoma Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/annonc\/mdz411","article-title":"Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Michielin","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.suc.2019.09.005","article-title":"Epidemiology and risk factors of melanoma","volume":"100","author":"Carr","year":"2020","journal-title":"Surg. Clin. N. Am."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","article-title":"Melanoma","volume":"392","author":"Schadendorf","year":"2018","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1039\/c7pp00411g","article-title":"Melanoma-role of the environment and genetics","volume":"17","author":"Cust","year":"2018","journal-title":"Photochem. Photobiol. Sci."},{"key":"ref_6","first-page":"6066","article-title":"Prognostic genes of melanoma identified by weighted gene co-expression network analysis and drug repositioning using a network-based method","volume":"18","author":"Wang","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41591-018-0265-6","article-title":"Ultraviolet radiation-induced DNA damage is prognostic for outcome in melanoma","volume":"25","author":"Trucco","year":"2019","journal-title":"Nat. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1080\/14656566.2019.1601700","article-title":"Current and emerging systemic therapies for cutaneous metastatic melanoma","volume":"20","author":"Mason","year":"2019","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1080\/15384047.2019.1640032","article-title":"Current state of melanoma diagnosis and treatment","volume":"20","author":"Davis","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13206-019-3108-8","article-title":"Current immunotherapy approaches for malignant melanoma","volume":"13","author":"Lim","year":"2019","journal-title":"BioChip J."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Pearce, A., Haas, M., Viney, R., Pearson, S.A., Haywood, P., Brown, C., and Ward, R. (2017). Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0184360"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Oncotarget"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3322\/caac.21565","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41591-019-0407-5","article-title":"Molecular profiling of cancer patients enables personalized combination therapy: The I-PREDICT study","volume":"25","author":"Sicklick","year":"2019","journal-title":"Nat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbcan.2019.02.002","article-title":"Many ways to resistance: How melanoma cells evade targeted therapies","volume":"1871","author":"Kozar","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/jdv.15446","article-title":"Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patients","volume":"33","author":"Rayner","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"MMT32","DOI":"10.2217\/mmt-2019-0016","article-title":"Prognostic gene expression profiling in melanoma: Necessary steps to incorporate into clinical practice","volume":"6","author":"Grossman","year":"2019","journal-title":"Melanoma Manag."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12253-019-00788-w","article-title":"KIT mutation incidence and pattern of melanoma in Central Europe","volume":"26","author":"Doma","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2019.10.027","article-title":"Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma","volume":"125","author":"Amaral","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12079-019-00510-0","article-title":"mTOR inhibitor Everolimus-induced apoptosis in melanoma cells","volume":"13","author":"Zarzycka","year":"2019","journal-title":"J. Cell Commun. Signal."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ijc.32756","article-title":"Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment","volume":"147","author":"Zhou","year":"2020","journal-title":"Int. J. Cancer."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/CMR.0000000000000647","article-title":"Anti-angiogenic effects of mangiferin and mechanism of action in metastatic melanoma","volume":"30","author":"Gonzalez","year":"2020","journal-title":"Melanoma Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2012.10.006","article-title":"What is behind the non-antibiotic properties of minocycline?","volume":"67","author":"Zarzuelo","year":"2013","journal-title":"Pharmacol. Res."},{"key":"ref_24","first-page":"e5351","article-title":"Reconsidering the use of minocycline in the preliminary treatment regime of rheumatoid arthritis","volume":"11","author":"Beckler","year":"2019","journal-title":"Cureus"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e00413","DOI":"10.1002\/rcr2.413","article-title":"Management of skin sarcoidosis with minocycline monotherapy","volume":"7","author":"Sasaki","year":"2019","journal-title":"Respirol. Case Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e13019","DOI":"10.1111\/dth.13019","article-title":"Nevoid hyperkeratosis of male breast: Successful treatment with minocycline","volume":"32","author":"Dabas","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.04.006","article-title":"The prospects of minocycline in multiple sclerosis","volume":"235","author":"Chen","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00415-018-8935-3","article-title":"Minocycline for acute stroke treatment: A systematic review and meta-analysis of randomized clinical trials","volume":"265","author":"Malhotra","year":"2018","journal-title":"J. Neurol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/02699052.2019.1566968","article-title":"Safety and feasibility of minocycline in treatment of acute traumatic brain injury","volume":"33","author":"Meythaler","year":"2019","journal-title":"Brain Inj."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.phrs.2018.07.002","article-title":"Minocycline as a promising therapeutic strategy for chronic pain","volume":"134","author":"Zhou","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11126-019-09707-3","article-title":"Minocycline for depressive symptoms: A meta-analysis of randomized, double-blinded, placebo-controlled trials","volume":"91","author":"Cai","year":"2020","journal-title":"Psychiatr. Q."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"212553","DOI":"10.7573\/dic.212553","article-title":"The therapeutic role of minocycline in Parkinson\u2019s disease","volume":"8","author":"Cankaya","year":"2019","journal-title":"Drugs Context."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: Far beyond an antibiotic","volume":"169","author":"Zarzuelo","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-14-3013","article-title":"Pancreatic cancer combination therapy using a BH3 mimetic and a synthetic tetracycline","volume":"75","author":"Quinn","year":"2015","journal-title":"Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12964-019-0384-9","article-title":"Minocycline impairs TNF-\u03b1-induced cell fusion of M13SV1-Cre cells with MDA-MB-435-pFDR1 cells by suppressing NF-\u03baB transcriptional activity and its induction of target-gene expression of fusion-relevant factors","volume":"17","author":"Weiler","year":"2019","journal-title":"Cell Commun. Signal."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijrobp.2019.10.010","article-title":"Minocycline reduces chemoradiation-related symptom burden in patients with non-small cell lung cancer: A phase 2 randomized trial","volume":"106","author":"Wang","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40257-015-0116-x","article-title":"Efficacy of prophylactic minocycline treatment for skin toxicities induced by erlotinib plus gemcitabine in patients with advanced pancreatic cancer: A retrospective study","volume":"16","author":"Shinohara","year":"2015","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1158\/1535-7163.MCT-17-0568","article-title":"Mechanism-informed repurposing of minocycline overcomes resistance to topoisomerase inhibition for peritoneal carcinomatosis","volume":"17","author":"Huang","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3892\/or.2014.3248","article-title":"Minocycline and cisplatin exert synergistic growth suppression on hepatocellular carcinoma by inducing S phase arrest and apoptosis","volume":"32","author":"Liu","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/S0022-5347(17)35268-0","article-title":"Inhibitory effect of minocycline on in vitro invasion and experimental metastasis of mouse renal adenocarcinoma","volume":"151","author":"Masumori","year":"1994","journal-title":"J. Urol."},{"key":"ref_41","first-page":"469","article-title":"The combined effects of celecoxib and minocycline hydrochloride on inhibiting the osseous metastasis of breast cancer in nude mice","volume":"23","author":"Niu","year":"2008","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.bbi.2011.01.015","article-title":"Minocycline reduces glioma expansion and invasion by attenuating microglial MT1-MMP expression","volume":"25","author":"Markovic","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/BF00686191","article-title":"The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism","volume":"36","author":"Powers","year":"1995","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0378-5173(01)00988-7","article-title":"Binding of doxycycline to keratin, melanin and human epidermal tissue","volume":"235","author":"Banning","year":"2002","journal-title":"Int. J. Pharm."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cbi.2019.02.005","article-title":"Chlortetracycline and melanin biopolymer\u2014The risk of accumulation and implications for phototoxicity: An in vitro study on normal human melanocytes","volume":"303","author":"Rok","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"ref_46","first-page":"1681","article-title":"The pivotal effect of suldinac on melanin-containing cancers","volume":"74","author":"Delijewski","year":"2017","journal-title":"Acta Pol. Pharm."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ygyno.2012.01.006","article-title":"Minocycline inhibits growth of epithelial ovarian cancer","volume":"125","author":"Pourgholami","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.yexcr.2013.11.012","article-title":"Tetracyclines cause cell stress-dependent atf4 activation and mtor inhibition","volume":"320","author":"Brem","year":"2014","journal-title":"Exp. Cell Res."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Pfeffer, C.M., and Singh, A.T.K. (2018). Apoptosis: A target for anticancer therapy. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020448"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.3390\/ijms16022942","article-title":"A time to kill: Targeting apoptosis in cancer","volume":"16","author":"Koff","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.ircmb.2016.06.006","article-title":"Metabolic regulation of apoptosis in cancer","volume":"327","author":"Matsuura","year":"2016","journal-title":"Int. Rev. Cell. Mol. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev-cancerbio-050216-121933","article-title":"Apoptosis and cancer","volume":"1","author":"Letai","year":"2017","journal-title":"Annu. Rev. Cancer Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00204-012-0906-3","article-title":"Oxidative stress in apoptosis and cancer: An update","volume":"86","author":"Segura","year":"2012","journal-title":"Arch. Toxicol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-1-61779-867-2_21","article-title":"Oxidative stress, thiols, and redox profiles","volume":"889","author":"Harris","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3892\/ijo.2013.2215","article-title":"Crosstalk between mitochondrial ROS and depolarization in the potentiation of TRAIL-induced apoptosis in human tumor cells","volume":"44","author":"Ochiai","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/cdd.2017.44","article-title":"Caspases and their substrates","volume":"24","author":"Julien","year":"2017","journal-title":"Cell Death Differ."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"a008656","DOI":"10.1101\/cshperspect.a008656","article-title":"Caspase functions in cell death and disease","volume":"5","author":"McIlwain","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4161\/auto.7.2.14043","article-title":"Minocycline inhibits the growth of glioma by inducing autophagy","volume":"7","author":"Liu","year":"2011","journal-title":"Autophagy"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Song, H., Fares, M., Maguire, K.R., Sid\u00e9n, A., and Pot\u00e1cov\u00e1, Z. (2014). Cytotoxic effects of tetracycline analogues (doxycycline, minocycline and COL-3) in acute myeloid leukemia HL-60 cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0114457"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jacc.2003.09.050","article-title":"Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac\/DIABLO, and reduces the mitochondrial leakage of cytochrome C and smac\/DIABLO","volume":"43","author":"Scarabelli","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000086610","article-title":"Minocycline partially inhibits caspase-3 activation and photoreceptor degeneration after photic injury","volume":"37","author":"Chang","year":"2005","journal-title":"Ophthalmic Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"10483","DOI":"10.1073\/pnas.1832501100","article-title":"Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington\u2019s disease","volume":"100","author":"Wang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/18\/6917\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:12:00Z","timestamp":1760177520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/18\/6917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":62,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["ijms21186917"],"URL":"https:\/\/doi.org\/10.3390\/ijms21186917","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,21]]}}}